{"id":"https://genegraph.clinicalgenome.org/r/d5ee3600-c212-42d8-a56c-9f5805baf7ecv1.2","type":"EvidenceStrengthAssertion","dc:description":"SNRNP200 gene was first reported in relation to SNRNP200-related dominant retinopathy, in a patient described with retinitis pigmentosa (adRP) in 2009 (PMID:19878916). Retinitis pigmentosa is characterized by nyctalopia (HP:0000662), reduced visual acuity (HP:0007663), rod-cone dystrophy (HP:0000510), attenuation of retinal blood vessels (HP:0007843), pigmentary retinopathy (HP:0000580), macular degeneration (HP:0000608), optic disc pallor (HP:0000543), abnormal (diminished) electroretinogram (HP:0000512), and bone spicule pigmentation of the retina (HP:0007737). To capture the overlapping spectrum of clinical presentations, this gene is curated under the disease entity \"inherited retinal dystrophy\". \nThough total score to reach a definitive classification was achieved by the addition of 27 variants (PMID: 23029027, 26720483, 21618346, 33553197, 33090715, 33598457, 19710410, 33576794, 30543658, 31486839, 26355662, 24516651, 24319334, 25356976, 32037395, 27208204) in this curation, however there is more evidence available in the literature. There are 17 SNRNP200 pathogenic and likely pathogenic variants listed on ClinVar (03/02/2022). SNRNP200 RNA was found to be highly expressed in cornea, iris, lens, vitreous body, sclera, retina, and optic nerve of the human cadaver eyes (PMID 33553197) while whole mount in situ hybridization in zebra fish revealed a generalized expression of SNRNP200 at two-cell stage, 50%-epiboly, 8-somite stage, 1pdf, and 2pdf. Furthermore, retinal cryosections showed high expression at the ciliary marginal zone at 3dpf and 5dpf (PMID 33553197). Overexpression of mutant SNRNP200 in knockout zebrafish caused generalized body and retinal defects through dominant negative effect, although in humans with SNRNP200 mutations, no systemic defects have been observed so far (PMID 33553197). \nIn summary, SNRNP200 is definitively associated with SNRNP200-related dominant retinopathy. This has been repeatedly demonstrated in both research and clinical diagnostic settings and has been upheld over time.  \n\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d5ee3600-c212-42d8-a56c-9f5805baf7ec","GCISnapshot":"https://genegraph.clinicalgenome.org/r/41acb15c-18a0-412b-a308-66a7f4e2837a","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:summaryChange"},{"id":"cg:sopChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/41acb15c-18a0-412b-a308-66a7f4e2837a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2022-07-12T13:24:01.377Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/41acb15c-18a0-412b-a308-66a7f4e2837a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10072","date":"2022-05-24T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41acb15c-18a0-412b-a308-66a7f4e2837a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/468f5763-b88a-46bd-ad99-f3f5701203de","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/468f5763-b88a-46bd-ad99-f3f5701203de_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878916","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a07c3c9-8b8f-424b-a367-98c7bc4c18b5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.3260C>T (p.Ser1087Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254265"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/468f5763-b88a-46bd-ad99-f3f5701203de_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Human BRR2 containing p.Ser1087Leu and p.R1090L variants were stably expressed in human cell culture by using BACs. \nThe cells expressing mutants BRR2 showed increased splicing efficiency of a house keeping gene LDHA. Furthermore, knockdown of endogenous BRR2 in parental HeLa cells significantly reduced the efficiency of LDHA and ZFP1 splicing which was restored by cells expressing wild type BRR2 but not by expression of p.Ser1087Leu  and p.R1090L mutant BRR2. The data suggested that BRR2 is an important factor in 5′-splice-site recognition while the mutant BRR2 impaired this function. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/65a7fe56-1b98-4b6d-8e49-e77cae56a31b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65a7fe56-1b98-4b6d-8e49-e77cae56a31b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23029027","allele":{"id":"https://genegraph.clinicalgenome.org/r/d13222d3-409d-490f-9dd4-b75cd439eeb6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2653C>G (p.Gln885Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261211"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a5f33728-5e3a-41c0-9fbc-04182dbb15ac","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5f33728-5e3a-41c0-9fbc-04182dbb15ac_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21618346","allele":{"id":"https://genegraph.clinicalgenome.org/r/00b7bcc0-1bd8-4b5d-9b2d-81c0eff709f7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2042G>A (p.Arg681His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA270107"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/858476da-fa70-4888-ae10-cbd50631a823","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/858476da-fa70-4888-ae10-cbd50631a823_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33598457","allele":{"id":"https://genegraph.clinicalgenome.org/r/a89a1c63-81cc-48cf-a2e5-cc89284167d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.1951C>T (p.Leu651Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347680164"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e73f91b6-d162-4134-a5ad-42c1046feeb3","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e73f91b6-d162-4134-a5ad-42c1046feeb3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33090715","allele":{"id":"https://genegraph.clinicalgenome.org/r/187341bb-61ef-4ac8-89c9-883f1cac5cdc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2816C>T (p.Ser939Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347675041"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/244a4352-ed26-4232-a7fd-b62a537d640e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/244a4352-ed26-4232-a7fd-b62a537d640e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33090715","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7e744db-db3a-44c2-92bf-3fae96d7eb7c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2359G>A (p.Ala787Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347677700"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a8ec7467-2be6-4c47-9599-1d8d72bea8ba","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8ec7467-2be6-4c47-9599-1d8d72bea8ba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26720483","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a07c3c9-8b8f-424b-a367-98c7bc4c18b5"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a8ec7467-2be6-4c47-9599-1d8d72bea8ba_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Human BRR2 containing p.Ser1087Leu and p.R1090L variants were stably expressed in human cell culture by using BACs. \nThe cells expressing mutants BRR2 showed increased splicing efficiency of a house keeping gene LDHA. Furthermore, knockdown of endogenous BRR2 in parental HeLa cells significantly reduced the efficiency of LDHA and ZFP1 splicing which was restored by cells expressing wild type BRR2 but not by expression of p.Ser1087Leu  and p.R1090L mutant BRR2. The data suggested that BRR2 is an important factor in 5′-splice-site recognition while the mutant BRR2 impaired this function. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8d054c7b-dd6c-45e9-a31a-0bdc2094bab3","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d054c7b-dd6c-45e9-a31a-0bdc2094bab3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27208204","allele":{"id":"https://genegraph.clinicalgenome.org/r/828be610-e686-4c2f-ac27-46524ee3f26e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2879C>T (p.Ala960Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1778604"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/77cf4999-58c1-491f-8814-487b62746486","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77cf4999-58c1-491f-8814-487b62746486_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33576794","allele":{"id":"https://genegraph.clinicalgenome.org/r/46453c7d-8b01-414a-927c-935a3b98b6fd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.1376A>T (p.Glu459Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347683019"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3cef9218-3edc-4655-a9f3-0c7d5b54ff3e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3cef9218-3edc-4655-a9f3-0c7d5b54ff3e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25356976","allele":{"id":"https://genegraph.clinicalgenome.org/r/49cce29b-f631-4ba6-9b25-9cd695f8ceef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.1631T>C (p.Met544Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347681976"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/64b50886-26bc-4664-ba9b-bab386ae50ee","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64b50886-26bc-4664-ba9b-bab386ae50ee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33553197","allele":{"id":"https://genegraph.clinicalgenome.org/r/8e09a9a2-7aa1-4a38-89ba-ad933897e8fb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.6088C>T (p.Arg2030Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/935525"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/64b50886-26bc-4664-ba9b-bab386ae50ee_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Morpholino oligonucleotide (MO) and SNRNP200 wild and mutant mRNA were injected into zebrafish embryos. It was observed that the mutant SNRNP200 cause systemic deformities, retinal defect as well as increased death rates in morphants. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/82d0d11b-ab57-4d95-ae4b-f8434030c3e4","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82d0d11b-ab57-4d95-ae4b-f8434030c3e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24319334","allele":{"id":"https://genegraph.clinicalgenome.org/r/9462788f-ef21-4008-9762-c955d8f356eb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2044C>T (p.Pro682Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347679545"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/199ffdb4-6521-4a07-842a-a22a6275281d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/199ffdb4-6521-4a07-842a-a22a6275281d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33598457","allele":{"id":"https://genegraph.clinicalgenome.org/r/ebb3abcc-a2c5-4986-a7c1-b3e309b23fa4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2599G>A (p.Gly867Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347676716"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ff8242ec-42d2-4ace-bbb3-d0a90076a9c9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff8242ec-42d2-4ace-bbb3-d0a90076a9c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33598457","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f875d5b-3852-4af4-9d1d-17f801918bfe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.1520C>T (p.Ala507Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347682405"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4f71ab1f-7ad8-4e39-a512-064fcf2f3407","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f71ab1f-7ad8-4e39-a512-064fcf2f3407_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21618346","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e37bdfb-08e7-4fdc-a5e9-8d6ed79d0e5c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2041C>T (p.Arg681Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/636112"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/08e2cb43-10ac-49ec-a203-4e6d4b05e2cd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08e2cb43-10ac-49ec-a203-4e6d4b05e2cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31486839","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7e744db-db3a-44c2-92bf-3fae96d7eb7c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9cde5d7e-45b6-47ee-b15b-c33f48aa9b2e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9cde5d7e-45b6-47ee-b15b-c33f48aa9b2e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30543658","allele":{"id":"https://genegraph.clinicalgenome.org/r/f61f391b-2960-4715-a0a7-01030ff51b38","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.1547G>T (p.Cys516Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347682307"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9513709f-d574-4d74-816a-3ddfa3fe0a3e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9513709f-d574-4d74-816a-3ddfa3fe0a3e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25356976","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d13e9f4-a343-4501-b1d2-62f7e1bf5c03","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.1614T>G (p.Ile538Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347682044"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3aa60b5a-8bc2-43f0-b547-dc80881a7635","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3aa60b5a-8bc2-43f0-b547-dc80881a7635_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33598457","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e37bdfb-08e7-4fdc-a5e9-8d6ed79d0e5c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/27244d69-6b10-4bf2-b4d0-f6a6c45e9f53","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27244d69-6b10-4bf2-b4d0-f6a6c45e9f53_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33598457","allele":{"id":"https://genegraph.clinicalgenome.org/r/00b7bcc0-1bd8-4b5d-9b2d-81c0eff709f7"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/eb43386f-7372-4b88-ae69-1438218ce629","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb43386f-7372-4b88-ae69-1438218ce629_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24516651","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c19d4ef-4be2-4035-bd8b-755124d895b6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2042G>T (p.Arg681Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347679554"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e5c2b799-3532-4488-b4cd-267dc461356a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5c2b799-3532-4488-b4cd-267dc461356a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21618346","allele":{"id":"https://genegraph.clinicalgenome.org/r/c957e70c-aff8-44a6-94a3-388d1f40ce0a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2047G>C (p.Val683Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347679535"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e5c2b799-3532-4488-b4cd-267dc461356a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Corresponding variant (snrp-200(cer23)) was created in C. elegans by using CRISPR editing. The mutants showed pleiotropic effects. A variety of phenotypic features included developmental defects, reduced brood size, larval arrest, larval morphological defects, dumpy animals and embryonic lethality. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dbd0dfdc-d151-4312-9c5b-0a11f3541493","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbd0dfdc-d151-4312-9c5b-0a11f3541493_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33090715","allele":{"id":"https://genegraph.clinicalgenome.org/r/55936cfd-4f31-4ceb-9b44-96b96c2a8826","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.3956G>A (p.Ser1319Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/866118"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6671e845-e990-4575-88f4-e675a48ef0eb","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6671e845-e990-4575-88f4-e675a48ef0eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33598457","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e37bdfb-08e7-4fdc-a5e9-8d6ed79d0e5c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4e818df3-638e-412a-8444-e110f1d728ce","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e818df3-638e-412a-8444-e110f1d728ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33598457","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7e744db-db3a-44c2-92bf-3fae96d7eb7c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4f720e09-1d28-499b-8ea9-8faa23816e60","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f720e09-1d28-499b-8ea9-8faa23816e60_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33598457","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a07c3c9-8b8f-424b-a367-98c7bc4c18b5"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/4f720e09-1d28-499b-8ea9-8faa23816e60_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Human BRR2 containing p.Ser1087Leu and p.R1090L variants were stably expressed in human cell culture by using BACs. The cells expressing mutants BRR2 showed increased splicing efficiency of a house keeping gene LDHA. Furthermore, knockdown of endogenous BRR2 in parental HeLa cells significantly reduced the efficiency of LDHA and ZFP1 splicing which was restored by cells expressing wild type BRR2 but not by expression of p.Ser1087Leu and p.R1090L mutant BRR2. The data suggested that BRR2 is an important factor in 5′-splice-site recognition while the mutant BRR2 impaired this function.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5c7311de-8dc6-404a-bcff-edaacf4471e5","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c7311de-8dc6-404a-bcff-edaacf4471e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32037395","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4d4cac1-e620-4e30-813d-3390cecd6935","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.1662C>G (p.Ser554Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347681853"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/77146881-ff9f-4ef2-a698-1eedbd13db2a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77146881-ff9f-4ef2-a698-1eedbd13db2a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19710410","allele":{"id":"https://genegraph.clinicalgenome.org/r/646b3160-f923-4ce4-af6b-a8360291c297","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.3269G>T (p.Arg1090Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261210"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/77146881-ff9f-4ef2-a698-1eedbd13db2a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Human BRR2 containing p.Ser1087Leu and p.R1090L variants were stably expressed in human cell culture by using BACs. The cells expressing mutants BRR2 showed increased splicing efficiency of a house keeping gene LDHA. Furthermore, knockdown of endogenous BRR2 in parental HeLa cells significantly reduced the efficiency of LDHA and ZFP1 splicing which was restored by cells expressing wild type BRR2 but not by expression of p.Ser1087Leu and p.R1090L mutant BRR2. The data suggested that BRR2 is an important factor in 5′-splice-site recognition while the mutant BRR2 impaired this function.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/17dfdbe6-7145-45cd-8b2a-c853ba481d1f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17dfdbe6-7145-45cd-8b2a-c853ba481d1f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27208204","allele":{"id":"https://genegraph.clinicalgenome.org/r/435f419c-5c54-4e88-976f-1627752c041a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.1871G>A (p.Arg624Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA270105"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d2e06077-5bf2-4d40-91ea-dd4b0ee91138","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2e06077-5bf2-4d40-91ea-dd4b0ee91138_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31486839","allele":{"id":"https://genegraph.clinicalgenome.org/r/f61f391b-2960-4715-a0a7-01030ff51b38"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/020ac5cb-7586-4060-9925-6b7d156d899d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/020ac5cb-7586-4060-9925-6b7d156d899d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33090715","allele":{"id":"https://genegraph.clinicalgenome.org/r/438c8755-80fc-442d-ad1b-ec8261d70080","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000002.12:g.96289381T>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347674539"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/41acb15c-18a0-412b-a308-66a7f4e2837a_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b60e3bd2-4439-4174-9255-5dcab3891e6d_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16612614","rdfs:label":"A","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/b60e3bd2-4439-4174-9255-5dcab3891e6d","type":"Family","rdfs:label":"A","ethnicity":{"id":"cg:UnknownEthnicity"}},"meetsInclusionCriteria":true,"phenotype":[{"id":"obo:HP_0000510"},{"id":"obo:HP_0000580"},{"id":"obo:HP_0007843"},{"id":"obo:HP_0007663"},{"id":"obo:HP_0000662"},{"id":"obo:HP_0000543"},{"id":"obo:HP_0000608"},{"id":"obo:HP_0000512"},{"id":"obo:HP_0007737"}],"phenotypePositiveAllelePositive":12,"publishedLodScore":4.69,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ca601966-f82a-4add-93f5-2c3202701544_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21618346","rdfs:label":"0270","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ca601966-f82a-4add-93f5-2c3202701544","type":"Family","rdfs:label":"0270","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b3d65a68-a12e-484e-a317-bb48924633f3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21618346","rdfs:label":"001-303","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e37bdfb-08e7-4fdc-a5e9-8d6ed79d0e5c"},"detectionMethod":"In this study, long range PCR was used to amplify 4 overlapping amplicons from patient DNA which was then pooled and subjected to high throughput sequencing by using Roche 454 GS FLX Titanium instrument. The data was analyzed on  software  package  CLC  Genomics  Workbench  (CLC  bio,  Aarhus,  Denmark). The variants validation and segregation analysis was done by standard Sanger sequencing. ","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Other","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4f71ab1f-7ad8-4e39-a512-064fcf2f3407_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"adRP","phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0000510","proband":{"id":"https://genegraph.clinicalgenome.org/r/b3d65a68-a12e-484e-a317-bb48924633f3"}},{"id":"https://genegraph.clinicalgenome.org/r/95cb233b-1faa-4a1c-a268-88ce2c53da63_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878916","rdfs:label":"A","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/95cb233b-1faa-4a1c-a268-88ce2c53da63","type":"Family","rdfs:label":"A","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/979960ce-1f46-4229-b1ab-3d10a2549b26","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878916","rdfs:label":"III-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a07c3c9-8b8f-424b-a367-98c7bc4c18b5"},"detectionMethod":"In one unaffected and two affected individuals (III:1, III:2, and III:8, Figure 2), coding exons and intron-exon boundaries were amplified by using specific primers and the amplicons were sequenced by standard Sanger sequencing method.\nSegregation analysis was done by using mutation specific primers and pyrosequencing assay\nrecommended by the manufacturer, with the use of PSQ 96 (Pyrosequencing AB, Uppsala, Sweden). ","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Sanger sequencing","previousTesting":true,"previousTestingDescription":"Linkage mapping and exclusion of candidate genes SEMA4C, CNGA3, HNK1ST, ADRA2B, MERTK by sequencing. ","secondTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/468f5763-b88a-46bd-ad99-f3f5701203de_variant_evidence_item"}}},"phenotypePositiveAllelePositive":12,"phenotypes":["obo:HP_0000662","obo:HP_0007663","obo:HP_0000510","obo:HP_0007737","obo:HP_0007843","obo:HP_0000512","obo:HP_0000608","obo:HP_0000580","obo:HP_0000543"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/979960ce-1f46-4229-b1ab-3d10a2549b26"},"publishedLodScore":4.69},{"id":"https://genegraph.clinicalgenome.org/r/e14cddaa-4d5e-4c2f-8c5f-c8c40a180df3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24516651","rdfs:label":"6ORG","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e14cddaa-4d5e-4c2f-8c5f-c8c40a180df3","type":"Family","rdfs:label":"6ORG","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/50632122-f3c3-4d4d-8c20-d29113add6f3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24516651","rdfs:label":"Patient 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c19d4ef-4be2-4035-bd8b-755124d895b6"},"detectionMethod":"Custom SNP-based chip which included 100 RD genes was used to genotype and then haplotype segregation was done. Sanger sequencing was used to detect variants in genes for which haplotype cosegregation was observed.  ","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Genotyping","phenotypeFreeText":"adRP","phenotypes":"obo:HP_0000510","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/eb43386f-7372-4b88-ae69-1438218ce629_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"adRP","phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0000510","proband":{"id":"https://genegraph.clinicalgenome.org/r/50632122-f3c3-4d4d-8c20-d29113add6f3"}},{"id":"https://genegraph.clinicalgenome.org/r/69365559-d5fe-4dc4-a052-e38ae1ce309c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19710410","rdfs:label":"TEH1","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/69365559-d5fe-4dc4-a052-e38ae1ce309c","type":"Family","rdfs:label":"TEH1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/dd9b4b93-2531-4025-a985-0b0024a6c4ec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19710410","rdfs:label":"19","ageType":"AgeAtReport","ageUnit":"Years","ageValue":45,"allele":{"id":"https://genegraph.clinicalgenome.org/r/646b3160-f923-4ce4-af6b-a8360291c297"},"detectionMethod":"Linkage mapping of 16 known IRD genes including PRPF3, SEMA4A, RHO, GUCA1B, RDS, PAP1, IMPDH1, RP1, TOPORS, ROM1, NRL, PRPF8, CA4, FSCN2, CRX, PRPF31 and RP33 locus was performed by using 34 polymorphic microsatellite markers. A LOD score of 3.5 was obtained at D2S2333 and 3.46 at D2S2216. These markers flank a region which harbors ASCC3L1/SNRNP200 gene. Sanger sequencing of the affected family member identified the variant in SNRNP200. Segregation was confirmed by using RFLP. ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/77146881-ff9f-4ef2-a698-1eedbd13db2a_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"adRP","phenotypePositiveAllelePositive":12,"phenotypes":["obo:HP_0000543","obo:HP_0007663","obo:HP_0000608","obo:HP_0007843","obo:HP_0000512","obo:HP_0000662","obo:HP_0007737","obo:HP_0000580","obo:HP_0000510"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/dd9b4b93-2531-4025-a985-0b0024a6c4ec"},"publishedLodScore":3.5,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/c0334eae-439c-4132-b647-82f367d0a69a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24319334","rdfs:label":"RFS048","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/c0334eae-439c-4132-b647-82f367d0a69a","type":"Family","rdfs:label":"RFS048","member":{"id":"https://genegraph.clinicalgenome.org/r/e28cc8d1-5f79-4740-bce0-3170e95461b1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24319334","rdfs:label":"4879","ageType":"AgeAtReport","ageUnit":"Years","ageValue":46,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7bd30a60-9306-40a9-a824-bbc5bdd6c621","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.1625C>T (p.Ala542Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347681997"}},"detectionMethod":"Standard Sanger sequencing. ","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Constricted visual fields as well. ","phenotypes":["obo:HP_0000512","obo:HP_0007663","obo:HP_0000510"],"previousTesting":true,"previousTestingDescription":"Unclear what tests were done but patients were selected in which previous tastings didn't identify causal variant. ","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2cb14b43-bda7-4f84-a755-2642f8b9131c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24319334","allele":{"id":"https://genegraph.clinicalgenome.org/r/7bd30a60-9306-40a9-a824-bbc5bdd6c621"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Constricted visual fields as well. ","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000512","obo:HP_0000510","obo:HP_0007663"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e28cc8d1-5f79-4740-bce0-3170e95461b1"}},{"id":"https://genegraph.clinicalgenome.org/r/7c85a996-9ade-44ac-a85a-9ee4777692dd_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33553197","rdfs:label":"Family-1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/7c85a996-9ade-44ac-a85a-9ee4777692dd","type":"Family","rdfs:label":"Family-1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ef99fb3c-b74d-45e6-abd9-80faf56769ad","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33553197","rdfs:label":"III-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8e09a9a2-7aa1-4a38-89ba-ad933897e8fb"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/64b50886-26bc-4664-ba9b-bab386ae50ee_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0007737","obo:HP_0007843","obo:HP_0000510","obo:HP_0007663","obo:HP_0000608","obo:HP_0000512","obo:HP_0000662","obo:HP_0000580","obo:HP_0000543"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/ef99fb3c-b74d-45e6-abd9-80faf56769ad"}},{"id":"https://genegraph.clinicalgenome.org/r/730a75f4-3613-4ba2-92b5-ad7a4e035b2a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23029027","rdfs:label":"B","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/730a75f4-3613-4ba2-92b5-ad7a4e035b2a","type":"Family","rdfs:label":"B","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c44bde13-e671-4e72-bea5-a0a682c2dcef","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23029027","rdfs:label":"III-9","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d13222d3-409d-490f-9dd4-b75cd439eeb6"},"detectionMethod":"Exome sequencing was performed on genomic DNA of the proband (III-9) followed by data processing and variant prioritization. Prioritized variants in USH2A, PDE6B and SNRNP200 genes were then subjected to segregation analysis by using standard Sanger sequencing.  ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/65a7fe56-1b98-4b6d-8e49-e77cae56a31b_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Open angle glaucoma was observed in two individuals (II-1, III-9). ","phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0000510","obo:HP_0000608","obo:HP_0007737","obo:HP_0000580","obo:HP_0007663","obo:HP_0012108","obo:HP_0000512","obo:HP_0000662","obo:HP_0000543","obo:HP_0007843"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/c44bde13-e671-4e72-bea5-a0a682c2dcef"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/77ef2af8-8a6d-41ab-ae90-4285193cdb0a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21618346","rdfs:label":"5632","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/77ef2af8-8a6d-41ab-ae90-4285193cdb0a","type":"Family","rdfs:label":"5632","ethnicity":{"id":"cg:NotHispanicOrLatino"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"adRP","phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0000510","proband":{"id":"https://genegraph.clinicalgenome.org/r/6d547809-d65d-4b52-ae26-a3e0b750e2b6"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.7},{"id":"https://genegraph.clinicalgenome.org/r/432053d8-b2c7-405b-aa40-f11a49566eaf","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/432053d8-b2c7-405b-aa40-f11a49566eaf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26355662","allele":{"id":"https://genegraph.clinicalgenome.org/r/8846d0ff-bc2d-4166-bb49-f1f4903ad13f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.6308A>G (p.Asn2103Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1777727"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2cb14b43-bda7-4f84-a755-2642f8b9131c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cb14b43-bda7-4f84-a755-2642f8b9131c_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/494bdd58-031c-45f7-9fdc-0afcf273f560","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/494bdd58-031c-45f7-9fdc-0afcf273f560_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26720483","allele":{"id":"https://genegraph.clinicalgenome.org/r/cafae8f6-989d-4959-93ec-33af4d191ee6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014014.5(SNRNP200):c.2122G>A (p.Val708Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/897977"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7.5},{"id":"https://genegraph.clinicalgenome.org/r/41acb15c-18a0-412b-a308-66a7f4e2837a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41acb15c-18a0-412b-a308-66a7f4e2837a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99200e69-ec60-4025-999d-91c1fbb1aaf9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7d10f63-15ba-4c62-a554-824a8ba7a2bd","type":"Finding","dc:description":"Expression of SNRNP200 gene was widely observed by using a commercial cDNA panel derived from human heart, brain, placenta, lung, liver, skeletal muscles, kidney and pancreas tissues. \n\nAdditionally, expression of SNRNP200 was also observed in multiple mice tissues including retina, and RPE-choroid-sclera eye cup. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878916","rdfs:label":"Expression of SNRNP200","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/be67055e-5025-4006-87e1-fab5b15881e9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/abb08859-04dd-42a1-8c51-dc70077dec2e","type":"Finding","dc:description":"RNA expression analysis in human cadaver eyes confirmed wide expression of SNRNP200 in multiple eye tissues including cornea, iris, lens, vitreous body, sclera, retina, and optic nerve. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33553197","rdfs:label":"RNA expression in human cadaver eyes","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6304978f-62af-4d34-80a3-0f4e868eb213","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f38f79ae-fdd5-4d1b-8345-141d49bb79e6","type":"Finding","dc:description":"Whole mount in situ hybridization in zebra fish revealed a generalized expression of SNRNP200 at two-cell stage, 50%-epiboly, 8-somite stage, 1pdf, and 2pdf. Retinal cryosections showed high expression at the ciliary marginal zone at 3dpf and 5dpf. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33553197","rdfs:label":"Whole mount in situ hybridization in zebra fish. ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/41acb15c-18a0-412b-a308-66a7f4e2837a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/305668e4-dd1d-4f06-bc3b-2baf74b4d9bc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b39635cb-f253-4c33-87ad-44a24e6f45f8","type":"Finding","dc:description":"Overexpression of mutant caused generalized body defects and retinal defects in zebrafish through dominant negative effect. In humans with SNRNP200 mutations, no systemic defects have been observed so far. However, still retinal defects were observed in mutants and this is a satisfactory evidence that SNRNP200 is required for normal retinal structure and function. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33553197","rdfs:label":"Overexpression of mutant SNRNP200 in kockout zebra fish.","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/29db8d15-a43d-43fe-a562-7cb0e0246d85","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9be3a2d-866c-4217-a517-a6ae0d895dc4","type":"Finding","dc:description":"This model system didn't recapitulate the human phenotype but the assays show that the variants tested are confer damaging effects. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19878916","rdfs:label":"Expression of mutant snrnp200 in budding yeast","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":4795,"specifiedBy":"GeneValidityCriteria9","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/PCsWR6QOre4","type":"GeneValidityProposition","disease":"obo:MONDO_0800098","gene":"hgnc:30859","modeOfInheritance":"obo:HP_0000006"},"version":"1.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_41acb15c-18a0-412b-a308-66a7f4e2837a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}